about
Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?Dormancy of metastatic melanomaBone metastasis: pathogenesis and therapeutic implications.A cellular automaton model for tumor dormancy: emergence of a proliferative switch.Models, mechanisms and clinical evidence for cancer dormancy.The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities.Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevanceWhy victory in the war on cancer remains elusive: biomedical hypotheses and mathematical models.Effects of Surgery and Chemotherapy on Metastatic Progression of Prostate Cancer: Evidence from the Natural History of the Disease Reconstructed through Mathematical Modeling.Review: Biological relevance of disseminated tumor cells in cancer patients.New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?Tumor dormancy of primary and secondary cancers.Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?Tumor dormancy and immunoescape.Cancer micrometastasis and tumour dormancy.Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines.Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.Suppression of Metastasis by Primary Tumor and Acceleration of Metastasis Following Primary Tumor Resection: A Natural Law?
P2860
Q30495334-13E8CE1F-F24B-44B5-8A78-FD37CC84B5B5Q33649569-4DE064E2-12E1-4C68-A18E-0016DA3C2B57Q34008243-2D47EA0B-12BF-4442-A2FC-5E5F88D905EEQ34351959-9BB2B4EF-0691-4704-85FD-6882BE671279Q36844303-4CA56D5F-5207-4D19-8786-D14C4B75B144Q36983954-A62B9AB9-0AA8-4E59-8623-4B5B1C18E0DFQ37001604-02D401A9-6208-40A8-AD41-AD2CBBD89D15Q37019257-7427A8A8-4539-49CE-980E-D19A6D042C71Q37129772-02F035C7-2DED-4FC0-83D5-45023CC90230Q37137460-3C950D4A-397C-4149-997D-36E21B74DA6AQ37246973-FA342DAE-6D56-4E79-BEE1-998126C30DAAQ37286235-FF122CD0-8449-4D7A-99D7-EC64FC2BA243Q37286241-84CF6A86-0C68-480B-89BA-20344672887FQ37286259-294573C0-5EBE-438B-9AA8-F3BA62510627Q37286268-CC15352B-06BB-4FBA-AAA8-122064A5C825Q37286285-ABCDDCC8-E710-4040-9D8C-4C175BE6086FQ37407134-A7A3232E-92CB-42D8-AD51-AC827784B8B4Q44496556-3749796E-CA1D-4503-9762-695A103E3232Q47568355-7F3A877F-752A-408C-B590-A187EDAC63CC
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cancer dormancy: from mice to man.
@ast
Cancer dormancy: from mice to man.
@en
type
label
Cancer dormancy: from mice to man.
@ast
Cancer dormancy: from mice to man.
@en
prefLabel
Cancer dormancy: from mice to man.
@ast
Cancer dormancy: from mice to man.
@en
P2093
P356
P1433
P1476
Cancer dormancy: from mice to man.
@en
P2093
Jonathan Uhr
Radu Marches
Richard Scheuermann
P304
P356
10.4161/CC.5.16.2995
P577
2006-08-15T00:00:00Z